Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06711003

Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.

Conditions

Interventions

TypeNameDescription
DEVICEenhanced external counterpulsationEnhanced External Counterpulsation (EECP) is a non-invasive treatment primarily used for patients with angina or heart failure. It involves the application of pressure cuffs to the legs, which inflate and deflate in sync with the cardiac cycle. This enhances blood flow to the heart during diastole, the phase when the heart is resting between beats. The increased pressure promotes coronary artery perfusion, helping to improve oxygen delivery to the heart muscle, reduce angina symptoms, and enhance cardiovascular function. EECP is typically recommended for patients who are not good candidates for invasive procedures like angioplasty or bypass surgery, or for those seeking supplementary treatment for angina. Over time, it may promote the development of new blood vessels (collateral circulation), further improving heart health. The treatment is generally administered over several weeks in outpatient settings, with each session lasting around one hour.
PROCEDUREpost acute carePost-Acute Care (PAC) for stroke patients focuses on improving functional independence, reducing disability, and preventing secondary complications.

Timeline

Start date
2024-10-22
Primary completion
2025-05-15
Completion
2025-05-15
First posted
2024-12-02
Last updated
2024-12-02

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06711003. Inclusion in this directory is not an endorsement.